mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron

Knowledge about the impact of prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of the elderly on mRNA vaccination response is needed to appropriately address the demand for additional vaccinations in this vulnerable population. Here, we show that octogenarians, a high-ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hye Kyung, Knabl, Ludwig, Moliva, Juan I., Werner, Anne P., Boyoglu-Barnum, Seyhan, Kapferer, Sebastian, Pateter, Birgit, Walter, Mary, Sullivan, Nancy J., Furth, Priscilla A., Hennighausen, Lothar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947943/
https://www.ncbi.nlm.nih.gov/pubmed/35395191
http://dx.doi.org/10.1016/j.celrep.2022.110680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947943/
https://www.ncbi.nlm.nih.gov/pubmed/35395191
http://dx.doi.org/10.1016/j.celrep.2022.110680

Ejemplares similares